Previous studies have shown that KIF18A is overexpressed in many cancers, including renal, breast, and hepatocellular carcinomas (Frisch and Screaton, 2001; Zhu et al., 2005; Mayr et al., 2007; Wagenbach, 2008; Zhang et al., 2010; Häfner et al., 2014; Kim et al., 2014; Braun et al., 2015; Czechanski et al., 2015; Okonogi et al., 2015; Shin et al., 2015; Chen et al., 2016; Kasahara et al., 2016; Wordeman et al., 2016; Möckel et al., 2017; Morgan and Mason, 2017; Pratt et al., 2017; Dai et al., 2018; Fotakopoulos et al., 2018; Jain, 2018; Luo et al., 2018). The gene discussed is KIF18A; the disease is cancer.